{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T09:09:46Z","timestamp":1779527386051,"version":"3.53.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"The Arthritis Foundation of Western Australia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40744-026-00850-5","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T03:58:31Z","timestamp":1775966311000},"page":"785-797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Frequency and Impact of Serious Infections in Hospitalised Patients with Sj\u00f6gren\u2019s Disease: A Longitudinal Cohort Study"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2833-7997","authenticated-orcid":false,"given":"Johannes C.","family":"Nossent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0535-963X","authenticated-orcid":false,"given":"Charles A.","family":"Inderjeeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,12]]},"reference":[{"issue":"1","key":"850_CR1","first-page":"97","volume":"379","author":"X Mariette","year":"2018","unstructured":"Mariette X, Criswell LA. Primary Sj\u00f6gren\u2019s syndrome. N Engl J Med. 2018;379(1):97.","journal-title":"N Engl J Med"},{"issue":"3","key":"850_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41584-023-01057-6","volume":"20","author":"M Beydon","year":"2024","unstructured":"Beydon M, McCoy S, Nguyen Y, Sumida T, Mariette X, Seror R. Epidemiology of Sj\u00f6gren syndrome. Nat Rev Rheumatol. 2024;20(3):158\u201369.","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"850_CR3","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1093\/rheumatology\/kez578","volume":"59","author":"P Brito-Zeron","year":"2020","unstructured":"Brito-Zeron P, Acar-Denizli N, Ng WF, Horvath IF, Rasmussen A, Seror R, et al. Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford). 2020;59(9):2350\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"850_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13293-017-0146-6","volume":"8","author":"JI Ramirez Sepulveda","year":"2017","unstructured":"Ramirez Sepulveda JI, Kvarnstrom M, Eriksson P, Mandl T, Norheim KB, Johnsen SJ, et al. Long-term follow-up in primary Sj\u00f6gren\u2019s syndrome reveals differences in clinical presentation between female and male patients. Biol Sex Differ. 2017;8(1):25.","journal-title":"Biol Sex Differ"},{"key":"850_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003866","author":"L Meudec","year":"2024","unstructured":"Meudec L, Debray MP, Beurnier A, Marques C, Juge PA, Dhote R, et al. Characterisation of airway disease associated with Sj\u00f6gren disease. RMD Open. 2024. https:\/\/doi.org\/10.1136\/rmdopen-2023-003866.","journal-title":"RMD Open"},{"issue":"Suppl 126(4)","key":"850_CR6","first-page":"271","volume":"38","author":"JH Reed","year":"2020","unstructured":"Reed JH, Verstappen GM, Rischmueller M, Bryant VL. When B cells break bad: development of pathogenic B cells in Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. 2020;38(Suppl 126(4)):271\u201382.","journal-title":"Clin Exp Rheumatol"},{"key":"850_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12185873","author":"Y Horai","year":"2023","unstructured":"Horai Y, Shimizu T, Umeda M, Nishihata SY, Nakamura H, Kawakami A. Current views on pathophysiology and potential therapeutic targets in Sj\u00f6gren\u2019s syndrome: a review from the perspective of viral infections, toll-like receptors, and long-noncoding RNAs. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12185873.","journal-title":"J Clin Med"},{"issue":"12","key":"850_CR8","first-page":"2531","volume":"42","author":"P Palla","year":"2024","unstructured":"Palla P, Chatzis LG, Sipsas NV, Goules AV, Tzioufas AG. Infections in Sj\u00f6gren\u2019s disease: a clinical concern or not? Clin Exp Rheumatol. 2024;42(12):2531\u201341.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"850_CR9","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/art.20176","volume":"50","author":"E Theander","year":"2004","unstructured":"Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sj\u00f6gren\u2019s syndrome: a prospective cohort study. Arthritis Rheum. 2004;50(4):1262\u20139.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"850_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","volume":"29","author":"FN Skopouli","year":"2000","unstructured":"Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sj\u00f6gren\u2019s syndrome. Semin Arthritis Rheum. 2000;29(5):296\u2013304.","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl 126(4)","key":"850_CR11","first-page":"47","volume":"38","author":"JA Singh","year":"2020","unstructured":"Singh JA, Cleveland JD. Serious infections in Sj\u00f6gren\u2019s syndrome patients: a national U.S. study. Clin Exp Rheumatol. 2020;38(Suppl 126(4)):47\u201352.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"850_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/rheumatology\/keg432","volume":"43","author":"A Schattner","year":"2004","unstructured":"Schattner A, Friedman J, Bentwich Z. Opportunistic infection due to unexplained CD4+ lymphocytopenia and associated Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford). 2004;43(1):111\u20132.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"850_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10067-013-2408-y","volume":"33","author":"YS Chang","year":"2014","unstructured":"Chang YS, Liu CJ, Ou SM, Hu YW, Chen TJ, Lee HT, et al. Tuberculosis infection in primary Sj\u00f6gren\u2019s syndrome: a nationwide population-based study. Clin Rheumatol. 2014;33(3):377\u201383.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"850_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s10067-023-06803-5","volume":"43","author":"X Zhou","year":"2024","unstructured":"Zhou X, Li H, Wang N, Jin Y, He J. Respiratory infection risk in primary Sj\u00f6gren\u2019s syndrome complicated with interstitial lung disease: a retrospective study. Clin Rheumatol. 2024;43(2):707\u201315.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"850_CR15","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s10067-022-06053-x","volume":"41","author":"ME Yayla","year":"2022","unstructured":"Yayla ME, Sahin Eroglu D, Uslu Yurteri E, Kelesoglu Dincer AB, Sezer S, Aydemir Guloksuz EG, et al. Indications and risk factors for hospitalization in patients with primary Sj\u00f6gren syndrome: experience from a tertiary center in Turkey. Clin Rheumatol. 2022;41(5):1457\u201363.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"850_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1467-842X.2002.tb00682.x","volume":"26","author":"CW Kelman","year":"2002","unstructured":"Kelman CW, Bass AJ, Holman CD. Research use of linked health data\u2014a best practice protocol. Aust N Z J Public Health. 2002;26(3):251\u20135.","journal-title":"Aust N Z J Public Health"},{"issue":"8","key":"850_CR17","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3899\/jrheum.101149","volume":"38","author":"S Bernatsky","year":"2011","unstructured":"Bernatsky S, Linehan T, Hanly JG. The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases. J Rheumatol. 2011;38(8):1612\u20136.","journal-title":"J Rheumatol"},{"issue":"4","key":"850_CR18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/art.41577","volume":"73","author":"JA Singh","year":"2021","unstructured":"Singh JA, Cleveland JD. Hospitalized infections in lupus: a nationwide study of types of infections, time trends, health care utilization, and in-hospital mortality. Arthritis Rheumatol. 2021;73(4):617\u201330.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"850_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s40744-023-00534-4","volume":"10","author":"JC Nossent","year":"2023","unstructured":"Nossent JC, Keen HI, Preen DB, Inderjeeth CA. Trends in hospitalization for tuberculosis and other opportunistic infections in Australian patients with inflammatory joint diseases. Rheumatol Ther. 2023;10(3):563\u201373.","journal-title":"Rheumatol Ther"},{"issue":"12","key":"850_CR20","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1177\/09612033221115965","volume":"31","author":"J Nossent","year":"2022","unstructured":"Nossent J, Keen H, Preen DB, Inderjeeth CA. Temporal trends in hospitalisation for opportunistic infections in Lupus patients in Western Australia. Lupus. 2022;31(12):1434\u201340.","journal-title":"Lupus"},{"issue":"10","key":"850_CR21","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/acr.23173","volume":"69","author":"G Maciel","year":"2017","unstructured":"Maciel G, Crowson CS, Matteson EL, Cornec D. Prevalence of primary Sj\u00f6gren\u2019s syndrome in a US population-based cohort. Arthritis Care Res (Hoboken). 2017;69(10):1612\u20136.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"850_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003591","author":"R Seror","year":"2024","unstructured":"Seror R, Chiche L, Beydon M, Desjeux G, Zhuo J, Vannier-Moreau V, et al. Estimated prevalence, incidence and healthcare costs of Sj\u00f6gren\u2019s syndrome in France: a national claims-based study. RMD Open. 2024. https:\/\/doi.org\/10.1136\/rmdopen-2023-003591.","journal-title":"RMD Open"},{"issue":"11","key":"850_CR23","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, et al. Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(11):1983\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"850_CR24","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s40744-021-00314-y","volume":"8","author":"A Westerlund","year":"2021","unstructured":"Westerlund A, Kejs AMT, Beydogan H, Gairy K. Primary Sj\u00f6gren\u2019s syndrome: a retrospective cohort study of burden of illness in Sweden. Rheumatol Ther. 2021;8(2):955\u201371.","journal-title":"Rheumatol Ther"},{"issue":"1","key":"850_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000575","volume":"4","author":"G Maciel","year":"2018","unstructured":"Maciel G, Servioli L, Nannini C, Berti A, Crowson CS, Achenbach SJ, et al. Hospitalisation rates among patients with primary Sj\u00f6gren\u2019s syndrome: a population-based study, 1995\u20132016. RMD Open. 2018;4(1):e000575.","journal-title":"RMD Open"},{"issue":"5","key":"850_CR26","first-page":"721","volume":"33","author":"Y Atisha-Fregoso","year":"2015","unstructured":"Atisha-Fregoso Y, Rivera-Vicencio Y, Banos-Pelaez M, Hernandez-Molina G. Main causes and risk factors for hospitalisation in patients with primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. 2015;33(5):721\u20135.","journal-title":"Clin Exp Rheumatol"},{"issue":"140","key":"850_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1183\/16000617.0011-2016","volume":"25","author":"T Flament","year":"2016","unstructured":"Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S. Pulmonary manifestations of Sj\u00f6gren\u2019s syndrome. Eur Respir Rev. 2016;25(140):110\u201323.","journal-title":"Eur Respir Rev"},{"key":"850_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211040696","volume":"13","author":"R Depascale","year":"2021","unstructured":"Depascale R, Del Frate G, Gasparotto M, Manfr\u00e8 V, Gatto M, Iaccarino L, et al. Diagnosis and management of lung involvement in systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome: a literature review. Ther Adv Musculoskelet Dis. 2021;13:1759720x211040696.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"5","key":"850_CR29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1136\/ard.51.5.604","volume":"51","author":"M Tishler","year":"1992","unstructured":"Tishler M, Caspi D, Almog Y, Segal R, Yaron M. Increased incidence of urinary tract infection in patients with rheumatoid arthritis and secondary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 1992;51(5):604\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"850_CR30","doi-asserted-by":"publisher","first-page":"592","DOI":"10.46497\/ArchRheumatol.2020.7427","volume":"35","author":"Z Cetin","year":"2020","unstructured":"Cetin Z, Mercan R, Karasahin O, Tufan A, Ozturk MA. Evaluation of asymptomatic bacteriuria and urinary tract infection in patients with primary Sj\u00f6gren\u2019s syndrome. Arch Rheumatol. 2020;35(4):592\u20139.","journal-title":"Arch Rheumatol"},{"key":"850_CR31","doi-asserted-by":"publisher","DOI":"10.3791\/66430","author":"X Wang","year":"2024","unstructured":"Wang X, Song Y, Lou X, Han B, Wu R, Xie J, et al. Examination of oral Candida infection in primary Sj\u00f6gren\u2019s syndrome patients. J Vis Exp. 2024. https:\/\/doi.org\/10.3791\/66430.","journal-title":"J Vis Exp"},{"key":"850_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.796324","volume":"8","author":"CL Chen","year":"2021","unstructured":"Chen CL, Chang FC, Hung YM, Chou MC, Yip HT, Chang R, et al. Candida infection as an early sign of subsequent Sj\u00f6gren\u2019s syndrome: a population-based matched cohort study. Front Med (Lausanne). 2021;8:796324.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"850_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.coms.2013.09.004","volume":"26","author":"JJ Nape\u00f1as","year":"2014","unstructured":"Nape\u00f1as JJ, Rouleau TS. Oral complications of Sj\u00f6gren\u2019s syndrome. Oral Maxillofac Surg Clin North Am. 2014;26(1):55\u201362.","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"2","key":"850_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.semarthrit.2017.03.004","volume":"47","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Kim KH, Hann HJ, Han S, Kim Y, Lee SH, et al. Incidence, mortality, and causes of death in physician-diagnosed primary Sj\u00f6gren\u2019s syndrome in Korea: a nationwide, population-based study. Semin Arthritis Rheum. 2017;47(2):222\u20137.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"850_CR35","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.mayocp.2017.01.020","volume":"92","author":"G Maciel","year":"2017","unstructured":"Maciel G, Crowson CS, Matteson EL, Cornec D. Incidence and mortality of physician-diagnosed primary Sj\u00f6gren syndrome: time trends over a 40-year period in a population-based US cohort. Mayo Clin Proc. 2017;92(5):734\u201343.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"850_CR36","first-page":"450","volume":"55","author":"AG Singh","year":"2016","unstructured":"Singh AG, Singh S, Matteson EL. Rate, risk factors and causes of mortality in patients with Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford). 2016;55(3):450\u201360.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"850_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/mr\/road010","volume":"34","author":"H Zhong","year":"2023","unstructured":"Zhong H, Wang Y, Yang P, Duan X, Wang Y, Xu J, et al. Hyperglobulinemia predicts increased risk of mortality in primary Sj\u00f6gren\u2019s syndrome: based on a Chinese multicentre registry. Mod Rheumatol. 2023;34(1):137\u201343.","journal-title":"Mod Rheumatol"},{"issue":"35","key":"850_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026777","volume":"100","author":"H Gao","year":"2021","unstructured":"Gao H, Sun Y, Zhang XY, Xie L, Zhang XW, Zhong YC, et al. Characteristics and mortality in primary Sj\u00f6gren syndrome-related interstitial lung disease. Medicine (Baltimore). 2021;100(35):e26777.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"850_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/rheumatology\/41.3.301","volume":"41","author":"JG Brun","year":"2002","unstructured":"Brun JG, Madland TM, Gjesdal CB, Bertelsen LT. Sj\u00f6gren\u2019s syndrome in an out-patient clinic: classification of patients according to the preliminary European criteria and the proposed modified European criteria. Rheumatology (Oxford). 2002;41(3):301\u20134.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"850_CR40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.autrev.2004.12.002","volume":"4","author":"H Locht","year":"2005","unstructured":"Locht H, Pelck R, Manthorpe R. Clinical manifestations correlated to the prevalence of autoantibodies in a large (n = 321) cohort of patients with primary Sj\u00f6gren\u2019s syndrome: a comparison of patients initially diagnosed according to the Copenhagen classification criteria with the American-European consensus criteria. Autoimmun Rev. 2005;4(5):276\u201381.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"850_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/03009740600759860","volume":"35","author":"MP Novljan","year":"2006","unstructured":"Novljan MP, Rozman B, Jerse M, Rotar Z, Vidmar G, Kveder T, et al. Comparison of the different classification criteria sets for primary Sj\u00f6gren\u2019s syndrome. Scand J Rheumatol. 2006;35(6):463\u20137.","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"850_CR42","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","volume":"42","author":"FB Vivino","year":"2016","unstructured":"Vivino FB, Carsons SE, Foulks G, Daniels TE, Parke A, Brennan MT, et al. New treatment guidelines for Sj\u00f6gren\u2019s disease. Rheum Dis Clin North Am. 2016;42(3):531\u201351.","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"850_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/13543784.2024.2312216","volume":"33","author":"X Zhou","year":"2024","unstructured":"Zhou X, Xu D, Li M, Zeng X. New investigational drugs to treat Sj\u00f6gren\u2019s syndrome: lessons learnt from immunology. Expert Opin Investig Drugs. 2024;33(2):105\u201314.","journal-title":"Expert Opin Investig Drugs"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-026-00850-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-026-00850-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-026-00850-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T08:46:36Z","timestamp":1779525996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-026-00850-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,12]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["850"],"URL":"https:\/\/doi.org\/10.1007\/s40744-026-00850-5","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,12]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Johannes Nossent has nothing to disclose and Charles Inderjeeth has nothing to disclose. Johannes Nossent is an Editorial Board member of Rheumatology and Therapy. Johannes Nossent was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study, including access to and the use of deidentified health data in the WARDER database, was approved by Western Australia Health Ethics Committee (HREC 2016.24, renewed in June 2021), which waived the need for informed consent for this project, that was performed in accordance with the Helsinki Declaration of 1964 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}